Published in Mol Cell Proteomics on November 09, 2010
NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data. PLoS One (2011) 1.20
High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Mol Cell Proteomics (2012) 1.19
Discovery of peptoid ligands for anti-aquaporin 4 antibodies. Chem Biol (2013) 1.07
Immunosignature system for diagnosis of cancer. Proc Natl Acad Sci U S A (2014) 1.02
Immunosignaturing can detect products from molecular markers in brain cancer. PLoS One (2012) 1.01
Physical characterization of the "immunosignaturing effect". Mol Cell Proteomics (2012) 1.00
GuiTope: an application for mapping random-sequence peptides to protein sequences. BMC Bioinformatics (2012) 0.99
Immunosignatures can predict vaccine efficacy. Proc Natl Acad Sci U S A (2013) 0.93
A liquid array platform for the multiplexed analysis of synthetic molecule-protein interactions. ACS Chem Biol (2013) 0.93
Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol (2012) 0.93
Impact of immunization technology and assay application on antibody performance--a systematic comparative evaluation. PLoS One (2011) 0.91
Hepatitis C virus antigenic convergence. Sci Rep (2012) 0.89
Diagnosis and early detection of CNS-SLE in MRL/lpr mice using peptide microarrays. BMC Immunol (2014) 0.84
Epitope identification from fixed-complexity random-sequence peptide microarrays. Mol Cell Proteomics (2014) 0.83
A technology for developing synbodies with antibacterial activity. PLoS One (2013) 0.80
Advances in blood-based protein biomarkers for Alzheimer's disease. Alzheimers Res Ther (2013) 0.79
Hydrogen/deuterium exchange mass spectrometry applied to IL-23 interaction characteristics: potential impact for therapeutics. Expert Rev Proteomics (2015) 0.77
Comparative study of classification algorithms for immunosignaturing data. BMC Bioinformatics (2012) 0.77
Segmentation and intensity estimation for microarray images with saturated pixels. BMC Bioinformatics (2011) 0.77
Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays. Mol Cell Proteomics (2014) 0.76
A General Method to Discover Epitopes from Sera. PLoS One (2016) 0.75
Hammock: a hidden Markov model-based peptide clustering algorithm to identify protein-interaction consensus motifs in large datasets. Bioinformatics (2015) 0.75
Antibody Repertoire Profiling with Mimotope Arrays. Hum Vaccin Immunother (2016) 0.75
Time-Frequency Analysis of Peptide Microarray Data: Application to Brain Cancer Immunosignatures. Cancer Inform (2015) 0.75
General Assessment of Humoral Activity in Healthy Humans. Mol Cell Proteomics (2016) 0.75
MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res (2006) 15.32
Antibody multispecificity mediated by conformational diversity. Science (2003) 5.21
Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput Biol (2008) 4.10
Efficient discovery of conserved patterns using a pattern graph. Comput Appl Biosci (1997) 3.94
Combinatorial pattern discovery in biological sequences: The TEIRESIAS algorithm. Bioinformatics (1998) 3.60
Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol (2003) 1.98
Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J Mol Biol (1995) 1.75
Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun (2007) 1.71
Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol (2001) 1.62
Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs (2007) 1.58
Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets (2004) 1.47
A general method for characterization of humoral immunity induced by a vaccine or infection. Vaccine (2010) 1.42
RELIC--a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites. Proteomics (2004) 1.42
Carboxy-terminal regions on the surface of tubulin and microtubules. Epitope locations of YOL1/34, DM1A and DM1B. J Mol Biol (1986) 1.31
Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol (1994) 1.25
Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds. J Am Chem Soc (2009) 1.15
Peptide microarrays for carbohydrate recognition. Analyst (2009) 1.10
Epitope mapping by phage display: random versus gene-fragment libraries. J Immunol Methods (1997) 1.08
Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J Immunol Methods (2002) 1.05
Multiple paths to multispecificity. Immunity (2006) 0.96
Bioinformatic requirements for protein database searching using predicted epitopes from disease-associated antibodies. Mol Cell Proteomics (2007) 0.93
High density peptide microarrays. In situ synthesis and applications. Mol Divers (2004) 0.90
Bacterial glycoprofiling by using random sequence peptide microarrays. Chembiochem (2009) 0.85
Antibody epitope mapping using de novo generated synthetic peptide libraries. Methods Mol Biol (2009) 0.83
Epitope discovery using monoclonal antibodies and phage peptide libraries. Comb Chem High Throughput Screen (1999) 0.82
Epitope mapping using randomly generated peptide libraries. Methods Mol Biol (2009) 0.81
Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide. Protein Sci (2001) 0.79
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci U S A (2004) 7.70
Recruitment of a 19S proteasome subcomplex to an activated promoter. Science (2002) 4.01
The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc Natl Acad Sci U S A (2004) 3.63
Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res (2002) 2.94
Physical and functional association of RNA polymerase II and the proteasome. Proc Natl Acad Sci U S A (2004) 1.61
Proteolytic turnover of the Gal4 transcription factor is not required for function in vivo. Nature (2006) 1.49
Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metastasis (2008) 1.44
A general method for characterization of humoral immunity induced by a vaccine or infection. Vaccine (2010) 1.42
High-level generation of polyclonal antibodies by genetic immunization. Nat Biotechnol (2003) 1.41
CT colonography computer-aided polyp detection: Effect on radiologist observers of polyp identification by CAD on both the supine and prone scans. Acad Radiol (2010) 1.41
The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One (2012) 1.35
Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett (2003) 1.34
The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Dev (2006) 1.32
A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry (2002) 1.30
Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J Biol Chem (2006) 1.27
ORF-FINDER: a vector for high-throughput gene identification. Gene (2002) 1.26
Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair. EMBO J (2006) 1.24
Application of immunosignatures to the assessment of Alzheimer's disease. Ann Neurol (2011) 1.17
Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice. J Neurol Sci (2007) 1.17
NADP regulates the yeast GAL induction system. Science (2008) 1.15
Peptide microarrays for carbohydrate recognition. Analyst (2009) 1.10
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer. Mol Cancer Ther (2008) 1.10
Physical and functional interactions of monoubiquitylated transactivators with the proteasome. J Biol Chem (2008) 1.08
The proteasomal ATPase complex is required for stress-induced transcription in yeast. Nucleic Acids Res (2006) 1.06
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci (2006) 1.05
In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. J Mol Biol (2004) 1.04
Short-range axonal/dendritic transport by myosin-V: A model for vesicle delivery to the synapse. J Neurobiol (2004) 1.03
Immunosignaturing can detect products from molecular markers in brain cancer. PLoS One (2012) 1.01
Physical characterization of the "immunosignaturing effect". Mol Cell Proteomics (2012) 1.00
GuiTope: an application for mapping random-sequence peptides to protein sequences. BMC Bioinformatics (2012) 0.99
Expression profiling of Yersinia pestis during mouse pulmonary infection. DNA Cell Biol (2006) 0.96
Activation domain-dependent monoubiquitylation of Gal4 protein is essential for promoter binding in vivo. J Biol Chem (2008) 0.96
Peptide-mediated targeting of the islets of Langerhans. Diabetes (2005) 0.94
Physical association of the APIS complex and general transcription factors. Biochem Biophys Res Commun (2002) 0.93
Discovery of high-affinity protein binding ligands--backwards. PLoS One (2010) 0.93
Immunosignatures can predict vaccine efficacy. Proc Natl Acad Sci U S A (2013) 0.93
Immunosignaturing: a critical review. Trends Biotechnol (2012) 0.93
Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol (2012) 0.93
The ketogenic diet for the treatment of glioma: insights from genetic profiling. Epilepsy Res (2011) 0.91
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells. Mol Cancer Ther (2006) 0.91
Feasibility of an early Alzheimer's disease immunosignature diagnostic test. J Neuroimmunol (2012) 0.91
A library-selected, Langerhans cell-targeting peptide enhances an immune response. DNA Cell Biol (2004) 0.90
Statistical methods for analyzing immunosignatures. BMC Bioinformatics (2011) 0.90
Thermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural information. PLoS One (2010) 0.88
Exploring peptide space for enzyme modulators. J Am Chem Soc (2010) 0.87
Identification of a protective antigen of Coccidioides immitis by expression library immunization. Vaccine (2003) 0.87
Drug-inducible, dendritic cell-based genetic immunization. J Immunol (2003) 0.86
Screening the whole genome of a pathogen in vivo for individual protective antigens. Vaccine (2005) 0.86
Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin. Infect Immun (2005) 0.85
Amplification of sense-stranded prokaryotic RNA. DNA Cell Biol (2006) 0.85
Bacterial glycoprofiling by using random sequence peptide microarrays. Chembiochem (2009) 0.85
Diagnosis and early detection of CNS-SLE in MRL/lpr mice using peptide microarrays. BMC Immunol (2014) 0.84
Phosphorylation of the Gal4 DNA-binding domain is essential for activator mono-ubiquitylation and efficient promoter occupancy. Mol Biosyst (2008) 0.83
Microarray technology displays the complexities of the humoral immune response. Expert Rev Mol Diagn (2011) 0.81
Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade. J Thorac Cardiovasc Surg (2010) 0.80
Role of B cells in vaccine-induced immunity against coccidioidomycosis. Infect Immun (2005) 0.80
A technology for developing synbodies with antibacterial activity. PLoS One (2013) 0.80
Autoreactive antibodies raised by self derived de novo peptides can identify unrelated antigens on protein microarrays. Are autoantibodies really autoantibodies? Exp Mol Pathol (2012) 0.80
Facile labeling of lipoglycans with quantum dots. Biochem Biophys Res Commun (2009) 0.79
Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge. Vaccine (2002) 0.78
A man-made ATP-binding protein evolved independent of nature causes abnormal growth in bacterial cells. PLoS One (2009) 0.78
Comparative study of classification algorithms for immunosignaturing data. BMC Bioinformatics (2012) 0.77
Engineering a synthetic ligand for tumor necrosis factor-alpha. Bioconjug Chem (2011) 0.77
Design and use of biomarkers for the current and future clinical management of brain tumors. Biomark Med (2012) 0.77
Thyroid hormone-dependent development in Xenopus laevis: a sensitive screen of thyroid hormone signaling disruption by municipal wastewater treatment plant effluent. Gen Comp Endocrinol (2012) 0.77
Segmentation and intensity estimation for microarray images with saturated pixels. BMC Bioinformatics (2011) 0.77
Cancer goal: Vaccine is cause for optimism. Nature (2013) 0.75
A scalable high-throughput chemical synthesizer. Genome Res (2002) 0.75
ICRPfinder: a fast pattern design algorithm for coding sequences and its application in finding potential restriction enzyme recognition sites. BMC Bioinformatics (2009) 0.75
Shotgun library construction in a day. Biotechniques (2003) 0.75
Could immunosignatures technology enable the development of a preventative cancer vaccine? Expert Rev Vaccines (2014) 0.75